Shuaihua Pu Selected Research

Rapeseed Oil

1/2018	Diets Low in Saturated Fat with Different Unsaturated Fatty Acid Profiles Similarly Increase Serum-Mediated Cholesterol Efflux from THP-1 Macrophages in a Population with or at Risk for Metabolic Syndrome: The Canola Oil Multicenter Intervention Trial.
12/2016	Dietary high oleic canola oil supplemented with docosahexaenoic acid attenuates plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels in participants with cardiovascular disease risk: A randomized control trial.
1/2016	Docosahexaenoic Acid Attenuates Cardiovascular Risk Factors via a Decline in Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Plasma Levels.
1/2016	Interactions between Obesity Status and Dietary Intake of Monounsaturated and Polyunsaturated Oils on Human Gut Microbiome Profiles in the Canola Oil Multicenter Intervention Trial (COMIT).
7/2014	DHA-enriched high-oleic acid canola oil improves lipid profile and lowers predicted cardiovascular disease risk in the canola oil multicenter randomized controlled trial.
4/2014	Plasma fatty acid changes following consumption of dietary oils containing n-3, n-6, and n-9 fatty acids at different proportions: preliminary findings of the Canola Oil Multicenter Intervention Trial (COMIT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuaihua Pu Research Topics

Disease

5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 04/2014
5	Abdominal Obesity 01/2018 - 04/2014
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 01/2016
2	Atherosclerosis 01/2018 - 02/2015
1	Body Weight (Weight, Body) 03/2016
1	Obesity 01/2016
1	Coronary Disease (Coronary Heart Disease) 07/2014
1	Septic Shock (Toxic Shock Syndrome) 02/2011
1	Foodborne Diseases 02/2011

Drug/Important Bio-Agent (IBA)

6	Rapeseed OilIBA 01/2018 - 04/2014
6	OilsIBA 01/2018 - 04/2014
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 04/2014
5	Oleic Acid (Oleate)IBA 01/2018 - 07/2014
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018 - 11/2016
2	Safflower Oil FDA Link 01/2018 - 07/2014
2	Docosahexaenoic AcidsIBA 12/2016 - 07/2014
1	Plant Oils (Vegetable Oils)IBA 01/2018
1	CholesterolIBA 01/2018
1	Corn Oil (Oil, Corn)IBA 01/2018
1	Proprotein Convertase 9IBA 12/2016
1	Monounsaturated Fatty AcidsIBA 11/2016
1	Unsaturated Dietary FatsIBA 03/2016
1	AcidsIBA 01/2016
1	oxidized low density lipoproteinIBA 02/2015
1	cholesteryl oleateIBA 02/2015
1	Proteoglycans (Proteoglycan)IBA 02/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 07/2014
1	LipidsIBA 07/2014
1	Enterotoxins (Enterotoxin)IBA 02/2011